(Q34267853)

1 August 2017

title

A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome (English)

1 reference

1 August 2017

11

Hagop M Kantarjian

1 reference

1 August 2017

1

Stefan Faderl

1 reference

1 August 2017

6

Zeev Estrov

1 reference

1 August 2017

10

Jorge Cortes

1 reference

1 August 2017

4

Farhad Ravandi

1 reference

1 August 2017

3

Elias Jabbour

1 reference

1 August 2017

5

Gautam Borthakur

1 reference

1 August 2017

Guillermo Garcia-Manero

series ordinal

2

object named as

Guillermo Garcia-Manero

1 reference

1 August 2017

9

Monica Kwari

1 reference

1 August 2017

Varsha Gandhi

7

1 reference

1 August 2017

Anna L Byrd

series ordinal

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

12 July 2011

1 reference

1 August 2017

1 reference

1 August 2017

volume

118

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

722-728

1 reference

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Clofarabine: past, present, and future

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Discovery and development of clofarabine: a nucleoside analogue for treating cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Myelodysplasic syndromes: a comprehensive review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

The World Health Organization (WHO) classification of the myeloid neoplasms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

International scoring system for evaluating prognosis in myelodysplastic syndromes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Monitoring accumulating data in a clinical trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180241

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

6 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26327

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26327

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26327

European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26327

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26327

Predicting survival and leukemic evolution in patients with myelodysplastic syndrome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21751197

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CNCR.26327

1 reference

1 August 2017

1 reference

1 August 2017

1 reference